scholarly article | Q13442814 |
case report | Q2782326 |
P2093 | author name string | Ankush Sharma | |
Rajesh Gulati | |||
Chandana Lall | |||
Joon-Il Choi | |||
Priya Bhosale | |||
Roozbeh Houshyar | |||
P2860 | cites work | Veno-occlusive disease in patients receiving thiopurines during maintenance therapy for childhood acute lymphoblastic leukaemia | Q33356939 |
Portal hypertension associated with oxaliplatin administration: clinical manifestations of hepatic sinusoidal injury | Q33386601 | ||
Oxaliplatin-mediated increase in spleen size as a biomarker for the development of hepatic sinusoidal injury | Q33389221 | ||
Metabolic and toxic effects of mithramycin during tumor therapy | Q33462982 | ||
Intestinal and liver toxicity of antineoplastic drugs | Q33605823 | ||
Hepatotoxicity of chemotherapy | Q33942794 | ||
Review article: updates in the pathogenesis and therapy of hepatic sinusoidal obstruction syndrome | Q34481791 | ||
Neoadjuvant treatment of colorectal liver metastases is associated with altered contrast enhancement on computed tomography | Q35495938 | ||
A prospective, randomized study on hepatotoxicity of anastrozole compared with tamoxifen in women with breast cancer | Q35713616 | ||
Pseudocirrhosis as a complication after chemotherapy for hepatic metastasis from breast cancer | Q36983555 | ||
Monoclonal antibodies for B-cell lymphomas: rituximab and beyond | Q37007354 | ||
Combined anti-proliferative and anti-angiogenic strategies for cancer | Q37111832 | ||
Pseudocirrhosis in a pancreatic cancer patient with liver metastases: a case report of complete resolution of pseudocirrhosis with an early recognition and management | Q37220914 | ||
Hepatic sinusoidal obstruction syndrome caused by herbal medicine: CT and MRI features | Q37640143 | ||
Sinusoidal obstruction syndrome after oxaliplatin-based chemotherapy. | Q37711334 | ||
Radiologic mimics of cirrhosis | Q37716391 | ||
CT findings of chemotherapy-induced toxicity: what radiologists need to know about the clinical and radiologic manifestations of chemotherapy toxicity | Q37823777 | ||
Cyclophosphamide-induced liver necrosis: a possible interaction with azathioprine | Q39550067 | ||
Morphologic spectrum of drug-induced hepatic disease | Q41072410 | ||
Evaluation of Possible Chronic Hepatotoxicity From Methotrexate for Psoriasis | Q42238881 | ||
Veno-occlusive liver disease after dacarbazine therapy (DTIC) for melanoma | Q42250859 | ||
Hepatic veno-occlusive disease due to DTIC. | Q42272033 | ||
Acute hepatic toxicity during cyclic chemotherapy in non Hodgkin's lymphoma | Q42982217 | ||
Development of cell-cycle inhibitors for cancer therapy | Q43145495 | ||
Hepatic veno-occlusive disease after myeloablative treatment and bone marrow transplantation: value of gray-scale and Doppler US in 100 patients | Q43909299 | ||
Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases | Q46515428 | ||
Hepatic capsular retraction in metastatic carcinoma of the breast occurring with increase or decrease in size of subjacent metastasis | Q47428622 | ||
Accuracy of gadoxetic acid-enhanced magnetic resonance imaging for the diagnosis of sinusoidal obstruction syndrome in patients with chemotherapy-treated colorectal liver metastases. | Q53397241 | ||
Acute portal vein thrombosis after autologous stem cell transplantation. | Q55066790 | ||
Impact of treatment-related liver toxicity on the outcome of HCV-positive non-Hodgkin's lymphomas | Q57718877 | ||
Thrombotic complications during L-asparaginase treatment for acute lymphocytic leukemia | Q67236664 | ||
Biliary sclerosis in patients receiving hepatic arterial infusions of floxuridine | Q67274373 | ||
Mechanisms of interleukin-2-induced hepatic toxicity | Q70908362 | ||
Drug-induced hepatotoxicity | Q71758942 | ||
CT of the liver in patients with metastatic breast carcinoma treated by chemotherapy: findings simulating cirrhosis | Q72888688 | ||
Portal vein thrombosis after hematopoietic cell transplantation: frequency, treatment and outcome | Q77769238 | ||
P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 3 | |
P921 | main subject | chemotherapy | Q974135 |
P304 | page(s) | 317-326 | |
P577 | publication date | 2014-09-01 | |
P1433 | published in | Clinical and molecular hepatology | Q26853927 |
P1476 | title | Chemotherapy induced liver abnormalities: an imaging perspective | |
P478 | volume | 20 |
Q58869838 | A New Model for MR Evaluation of Liver Function with Gadoxetic Acid, Including Both Uptake and Excretion |
Q36307995 | Cancer therapy related complications in the liver, pancreas, and biliary system: an imaging perspective |
Q88636540 | Effect of ursodeoxycholic acid and vitamin E in the prevention of liver injury from methotrexate in pediatric leukemia |
Q60045418 | IDEAL-IQ in an oncologic population: meeting the challenge of concomitant liver fat and liver iron |
Q90754497 | Preclinical evaluation of local prolonged release of paclitaxel from gelatin microspheres for the prevention of recurrence of peritoneal carcinomatosis in advanced ovarian cancer |
Q41951885 | Pseudocirrhosis in Gastric Cancer with Diffuse Liver Metastases after a Dramatic Response to Chemotherapy |
Q92292207 | Quantitative magnetic resonance imaging evaluation of hepatic fat content with iron deposition: will it be disturbed? |
Q38923545 | State-of-the-art cross-sectional liver imaging: beyond lesion detection and characterization |
Q90533360 | Targeted Delivery of Cisplatin-Derived Nanoprecursors via a Biomimetic Yeast Microcapsule for Tumor Therapy by the Oral Route |
Q28066568 | The Utilization of the Immune System in Lung Cancer Treatment: Beyond Chemotherapy |
Search more.